Celcuity (CELC) Competitors $49.22 +1.41 (+2.95%) Closing price 04:00 PM EasternExtended Trading$49.20 -0.02 (-0.05%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. GH, RDNT, BTSG, SHC, OPCH, WGS, PRVA, SGRY, HTFL, and CONShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), Surgery Partners (SGRY), Heartflow (HTFL), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Celcuity vs. Its Competitors Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Privia Health Group Surgery Partners Heartflow Concentra Group Holdings Parent Celcuity (NASDAQ:CELC) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Do analysts recommend CELC or GH? Celcuity presently has a consensus target price of $56.50, suggesting a potential upside of 14.79%. Guardant Health has a consensus target price of $65.86, suggesting a potential upside of 3.81%. Given Celcuity's higher possible upside, research analysts clearly believe Celcuity is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Celcuity 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67Guardant Health 1 Sell rating(s) 0 Hold rating(s) 23 Buy rating(s) 0 Strong Buy rating(s) 2.92 Which has preferable earnings and valuation, CELC or GH? Celcuity has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelcuityN/AN/A-$111.78M-$3.45-14.27Guardant Health$828.85M9.54-$436.37M-$3.35-18.94 Is CELC or GH more profitable? Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -49.93%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets CelcuityN/A -150.07% -64.67% Guardant Health -49.93%N/A -28.95% Which has more risk & volatility, CELC or GH? Celcuity has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Does the media favor CELC or GH? In the previous week, Guardant Health had 2 more articles in the media than Celcuity. MarketBeat recorded 7 mentions for Guardant Health and 5 mentions for Celcuity. Celcuity's average media sentiment score of 0.60 beat Guardant Health's score of 0.33 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 1 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of CELC or GH? 63.3% of Celcuity shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 15.8% of Celcuity shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryGuardant Health beats Celcuity on 9 of the 15 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.09B$3.32B$6.11B$10.53BDividend YieldN/A2.29%5.51%4.67%P/E Ratio-14.2721.6185.6926.92Price / SalesN/A424.41583.01184.15Price / CashN/A46.3226.3031.10Price / Book15.8310.0613.246.71Net Income-$111.78M-$52.22M$3.30B$276.35M7 Day Performance-0.36%5.87%4.64%3.10%1 Month Performance-11.62%12.07%8.36%10.19%1 Year Performance222.33%26.14%87.97%40.37% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity2.3561 of 5 stars$49.22+2.9%$56.50+14.8%+217.9%$2.09BN/A-14.2740GHGuardant Health3.7357 of 5 stars$61.99+3.3%$65.25+5.3%+186.0%$7.49B$739.02M-18.502,021Analyst ForecastRDNTRadNet3.0851 of 5 stars$74.70-1.6%$76.80+2.8%+14.0%$5.84B$1.91B-373.4811,021Positive NewsBTSGBrightSpring Health Services3.2574 of 5 stars$28.13+2.7%$27.10-3.7%+95.6%$4.85B$12.57B90.7435,000Analyst ForecastSHCSotera Health2.6053 of 5 stars$15.75-0.4%$16.00+1.6%+2.7%$4.49B$1.10B196.903,000Analyst ForecastOPCHOption Care Health4.8779 of 5 stars$27.54+0.9%$35.75+29.8%-6.2%$4.43B$5.00B22.038,088Positive NewsWGSGeneDx2.3222 of 5 stars$113.93-2.8%$104.13-8.6%+141.2%$3.37B$362.32M2,278.601,200PRVAPrivia Health Group3.8519 of 5 stars$24.42+1.9%$28.58+17.0%+37.2%$2.94B$1.74B222.021,140SGRYSurgery Partners2.7648 of 5 stars$21.91+0.3%$32.88+50.0%-34.6%$2.80B$3.11B-15.3215,000Analyst ForecastHTFLHeartflowN/A$34.50+4.4%$36.60+6.1%N/A$2.76B$148.54M0.00699Gap UpCONConcentra Group Holdings Parent2.8954 of 5 stars$20.79-0.2%$27.75+33.5%-1.5%$2.67B$1.90B17.4711,250 Related Companies and Tools Related Companies Guardant Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Option Care Health Competitors GeneDx Competitors Privia Health Group Competitors Surgery Partners Competitors Heartflow Competitors Concentra Group Holdings Parent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
